BA treatment slightly increased Bax and Caspase-3 levels while decreasing Bcl-2 expression, consistent with studies showing that betulinic acid suppresses tumor growth through activation of mTOR-regulated apoptotic signaling and modulation of the Bax/Bcl-2/caspase axis. Here, BCL2 is linked to neoplasm.